Addus Homecare Corp. Stock
€98.00
Your prediction
Addus Homecare Corp. Stock
Pros and Cons of Addus Homecare Corp. in the next few years
Pros
Cons
Performance of Addus Homecare Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Addus Homecare Corp. | 2.620% | 5.525% | 2.688% | 28.188% | 13.690% | 22.436% | 60.074% |
| Surgery Partners Inc | 0.790% | 8.621% | -0.787% | -20.755% | -12.500% | -40.566% | 175.560% |
| Capital Senior Living Corp. | 2.010% | -3.247% | 19.200% | 376.800% | 244.509% | -20.745% | -46.624% |
| Healthstream Inc. | -0.790% | 3.306% | - | - | - | - | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Addus Homecare (ADUS) is a reputable company in the Healthcare Providers & Services industry. At first glance, the financials of ADUS seem to present a stable and growing company with substantial assets and revenue. However, a thorough analysis of the financial statements reveals prominent pros and cons that a discerning investor should consider.
Growing Revenue: The total revenue of ADUS has shown a consistent growth over the past three years, increasing from $764.775 million in 2020 to $864.499 million in 2021, and further to $951.120 million in 2022. Revenue growth is an essential indicator of a company's success and expansion in its market.
Solid Gross Profit: ADUS has maintained a healthy gross profit throughout the analyzed years, with the figures reading $226.237 million in 2020, $269.848 million in 2021, and $299.739 million in 2022. These figures indicate that the company has been effectively managing its cost of operations and generating solid returns on its sales.
Comments
